Human CD52 (Research Grade Alemtuzumab Biosimilar) Biotinylated Antibody FAB9889B-100: R&D Systems
CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells | Cellular & Molecular Immunology
CD52/GPI− T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
Frontiers | CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer